Nephritic Pharmaceutical Private Limited
About Nephritic Pharmaceutical Private Limited
Data last updated:
Nephritic Pharmaceutical Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2023.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U46497UP2023PTC180237. Its GSTIN is 09AAICN8163C1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankit Singh and Ganga Rawat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 789/Santoshi Mata Madnir Madhinath, Bareilly, Uttar Pradesh, India – 243001.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address789/Santoshi Mata Madnir Madhinath, Bareilly, Uttar Pradesh, India – 243001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Board of Directors of Nephritic Pharmaceutical Private Limited
Nephritic Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Singh | Director | 18 Apr 2023 | 3 Years 5 Months | Current |
| Ganga Rawat | Director | 18 Apr 2023 | 3 Years 5 Months | Current |
Financials of Nephritic Pharmaceutical Private Limited FY 2025 filings available
Financial Statement Summary of Nephritic Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | •••• | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Nephritic Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | •••• |
| Net Profit Margin | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nephritic Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nephritic Pharmaceutical Private Limited
Nephritic Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nephritic Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Nephritic Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nephritic Pharmaceutical Private Limited
Nephritic Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICN8163C1ZB | Uttar Pradesh | Active | 23 Jul 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nephritic Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nephritic Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nephritic Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nephritic Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nephritic Pharmaceutical Private Limited
Frequently Asked Questions about Nephritic Pharmaceutical Private Limited
Nephritic Pharmaceutical is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2023 (3+ years old) and is registered under CIN U46497UP2023PTC180237.
Nephritic Pharmaceutical has 2 current directors:
- Ankit Singh - Director
- Ganga Rawat - Director
The GSTIN of Nephritic Pharmaceutical is 09AAICN8163C1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nephritic Pharmaceutical is U46497UP2023PTC180237. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nephritic Pharmaceutical was incorporated on 18 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The registered office of Nephritic Pharmaceutical is at 789Santoshi Mata Madnir Madhinath, Bareilly, Uttar Pradesh, India – 243001.
Nephritic Pharmaceutical has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Nephritic Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Nephritic Pharmaceutical is not listed on any stock exchange. It is an unlisted company.